22/04/2015 - 18:31 A detailed survival analysis questions the rationale behind use of the diabetes drug metformin to improve pancreatic cancer survival. Several epidemi... More » Visit websiteField of Interest: OncologyCategories: CEN || DOE: Type 2CEN || NewsONCR || NewsONCR || GastrointestinalONCR || GI: PancreaticFPN || NewsFPN || DiabetesEndocrinology & MetabolismNews Feed: Internal Medicine News - Oncology
